Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
Date:6/26/2009

DETROIT, June 26 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD), in an effort to update our shareholders, is providing additional information in regards to our financial position in light of the recent FDA action. The products in our inventory related to the FDA action are currently being identified. The early estimated value of this inventory is in the range of $15 to $20 million.

The products subject to seizure do not impact products on hand manufactured by third parties under their own label or manufactured for Caraco under the Caraco label. It also does not impact products recently sold into the market manufactured by Caraco.

Based on the estimated sales of distributed products and Caraco products manufactured by third parties, we believe that the profit generated from those products will cover our estimated ongoing expenses. Further, our cash balance as of June 25, 2009 is approximately $64 million which includes a loan of $18 million. Accordingly, we expect that our financial position will allow the Company the time to resolve its pending FDA issues.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA Inspection
3. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size Variability
6. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
7. Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009
8. Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning Letter
9. Caraco Pharmaceutical Laboratories, Ltd. Update on FDA Warning Letter
10. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Sinemet(R) Tablets
11. Caraco Pharmaceutical Laboratories, Ltd. Reaches Agreement with Labor Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... The Wireline Services Market in Europe report ... analysis and forecast of revenue. The Wireline services market in ... 2013 to $2.4 billion by 2019, at a CAGR of ... of the Wireline Services Market in Europe report, to get ... a glimpse of the segmentation in the European Wireline Services ...
(Date:7/28/2014)... 28, 2014 (HealthDay News) -- People with higher levels ... and diabetes, a new study suggests. Unlike white ... fat actually improves insulin sensitivity, blood sugar control and ... and obese people," Labros Sidossis, a professor of internal ... University of Texas Medical Branch at Galveston, said ...
(Date:7/28/2014)... July 28, 2014 In response to ... face today, BlogHer, The Center for American Progress and ... Life Work,” a campaign to raise awareness and promote ... the U.S. The joint initiative was announced on Saturday ... BlogHer; Judith Warner, Senior Fellow, The Center for American ...
(Date:7/28/2014)... Irresistible infants have met their match with a ... online gifting company specializes in homemade chicken noodle soup and creates ... package starts with home-from-the-hospital essentials every new parent will love:, ... rolls , 6 cookies , a ladle ... ready to heat and eat upon delivery, so parents can relax ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
Breaking Medicine News(10 mins):Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Healthy 'Brown Fat' May Cut Odds for Obesity, Diabetes 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4
... who practiced for nearly 30 years in a small medical ... of the American College of Physicians (ACP) testified today before ... half of our members who are involved in direct patient ... 20 percent of these physicians are in solo practices," the ...
... YORK, March 18 The International Trachoma Initiative (ITI) ... announced today that they will join forces to leverage ... Trachoma, a Neglected Tropical Disease (NTD) that is ... million people in 56 countries. While trachoma can be ...
... time to progress and cause real damage, doctors say , , ... Richardson may have suffered critical brain damage after a seemingly ... many people wondering how this could happen. , But experts ... as relatively benign as a concussion, to potentially lethal brain ...
... birth rate declined slightly in 2007 a finding that the ... a new trend in improved maternal and infant health. , ... gestation (late preterm) and among babies born to African American and ... birth rate, and hope that the emphasis we,ve put on the ...
... Educate Customers on AntibioticsLANDOVER, Md., March 18 ... free antibiotic program through July 11, 2009. The Company, ... District of Columbia, will continue to provide free of ... and their Giant BonusCard. The initial program launched on ...
... of family skiing in Canada ended with actress Natasha Richardson hospitalized with ... the exception and not the rule, the American Academy of Orthopaedic Surgeons ... on the slopes., , ... those frigid temperatures can produce on the ski slopes , ...
Cached Medicine News:Health News:Medicine's small business practices should be supported by federal budget 2Health News:International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases 2Health News:Brain Hemorrhage May Explain Natasha Richardson's Condition 2Health News:Brain Hemorrhage May Explain Natasha Richardson's Condition 3Health News:Giant Food Extends Its Free Antibiotic Prescription Program Through July 11, 2009 2Health News:Media Alert: Tips on Skiing Safely From the American Academy of Orthopaedic Surgeons 2
(Date:7/28/2014)... , July 28, 2014  MedSpring Urgent Care, an ... clinic at 517 S. Lamar Blvd., Austin, TX ... clinic is located on the southeast corner of Barton Springs ... from 9 a.m. - 9 p.m. daily, including weekends and holidays. ... Texas, Central Austin , Anderson Mill , ...
(Date:7/28/2014)...  TNI BioTech, Inc. (OTCQB: TNIB) ("TNIB" or ... development, marketing and distribution of opioid-related immunotherapies, announced ... with the Securities and Exchange Commission in connection ... be held on Thursday, September 4, 2014, at ... for determining those shareholders eligible to receive notice ...
(Date:7/28/2014)... July 28, 2014 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China , ... of Directors declared a special cash dividend of US$0.30 ... ("ADS")) on the Company,s outstanding ordinary shares. The total ...
Breaking Medicine Technology:MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3Concord Medical Declares Special Dividend 2
... 2011 ViroPharma Incorporated (Nasdaq: VPHM ) today ... ViroPharma, will present at the Citi 2011 Global Healthcare Conference ... conference is being held at the Hilton New York Hotel ... and chief financial officer, of ViroPharma, will present at the ...
... Feb. 28, 2011 Rock Creek Pharmaceuticals, a wholly ... CIGX ) has been notified by the Roskamp Institute ... review board (IRB) approval to conduct a three-month, multi-site ...  The study (referred to as the "Flint Study"), will ...
Cached Medicine Technology:ViroPharma to Participate in Two March Healthcare Conferences 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 3Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: